3 Japanese Dividend Stocks Retail Investors May Want To Watch Now
US long end bond yields have pushed higher as investors focus on inflation risk and the path of interest rates. When income from cash and bonds moves around, dependable dividend income can look more appealing. That is where Dividend Powerhouses with yields above 5% and well covered, growing payouts come in. This article highlights three stocks from that screener that can help anchor an income focused portfolio.
The stocks covered below are just a small sample of this idea, and the full screen surfaced 456 more companies with equally compelling dividend stories that are not covered here. To identify and analyze income ideas that best fit your own goals, head straight into the Dividend Powerhouses (3%+ Yield) screener.
Canon (TSE:7751)
Overview: Canon is a Japanese electronics group that develops and sells printers, cameras, medical imaging systems and industrial equipment used in offices, hospitals and factories around the world.
Operations: Canon generates most of its revenue from the Printing segment at about ¥2.5t, with additional scale from Imaging at about ¥1.1t, Medical at about ¥579b and Industrial at about ¥347b.
Market Cap: ¥3.95t
Canon may appeal to dividend focused investors who want exposure to established technology and medical equipment. The company is assessed as trading at a discount to an estimated fair value, with a lower P/E than many peers, while recent results show net profit margins at 7.4% and high quality earnings. H1 FY2026 sales and net income were both higher than the prior year, and Canon is actively buying back stock, with around 4.5% of shares repurchased under its latest plan. Investors need to weigh an unstable dividend record, higher funding risk and some governance questions, which makes deeper research especially important for anyone relying on Canon for long term income.
Canon’s lower P/E and stock buybacks hint at a story that many income investors may be underestimating. See how that picture changes once you factor in the 4 key rewards and 1 important warning sign.
Build your own dividend shortlist around Canon
Canon and the other two stocks in this article all came from a single Simply Wall St screen, but the real value is in shaping filters around what matters most to you. Put our flexible Screener to work by mixing dividend strength, valuation and balance sheet quality, or tap into ready made themes with our Investing Ideas.
Tokio Marine Holdings (TSE:8766)
Overview: Tokio Marine Holdings is a global insurer that offers a wide range of non life and life insurance products, retirement services, risk management and financial services for individuals, companies and institutions in Japan, the United States and other international markets.
Operations: Tokio Marine Holdings generates most of its revenue from Overseas Insurance Business at about ¥5.4t, with additional scale from Domestic Property and Casualty Insurance at about ¥3.2t, Domestic Life Insurance at about ¥445b and Solution and Other Business at about ¥328b, partly offset by unallocated adjustments of about ¥140b.
Market Cap: ¥14.3t
Income focused investors may want to look closely at Tokio Marine Holdings because it combines a 3.29% dividend with an active buyback program and a long operating history in insurance. The company is investing in areas like carbon credit insurance through its partnership with UK based Kita, which shows how it is building exposure to newer forms of risk transfer. At the same time, earnings and margins have been volatile, the P/E sits well above the industry average and funding relies on external borrowing rather than deposits. That mix of dependable income, expansion into specialty lines and balance sheet and valuation questions makes Tokio Marine a stock where deeper research could be well rewarded for patient dividend investors.
Tokio Marine’s mix of a 3.29% dividend, overseas scale and new lines like carbon credit insurance can look mispriced compared with its higher P/E rivals. The full picture only comes into focus once you weigh the 3 key rewards and 1 important warning sign
Daiichi Sankyo Company (TSE:4568)
Overview: Daiichi Sankyo Company is a global pharmaceutical group focused on prescription drugs for cancer, cardiovascular disease, pain and central nervous system disorders, as well as vaccines for conditions such as influenza, measles, mumps and COVID 19.
Operations: Daiichi Sankyo Company generates all of its revenue, about ¥2.2t, from its Pharmaceutical Operation segment.
Market Cap: ¥4.97t
Daiichi Sankyo Company stands out in a dividend focused shortlist because its 3.75% yield sits on top of an oncology franchise that includes Enhertu and Datroway, where recent EU, US and China approvals are widening treatment use across multiple cancer types. Forecast earnings growth of around 12.85% per year and recent revenue guidance upgrades are being weighed against a dividend that is not well covered by free cash flow and a high R&D bill that leans on external borrowing, including a fresh ¥200b loan in June 2026. For investors willing to accept concentration in a handful of blockbuster drugs and tighter payout cover, the combination of a 3% plus yield and oncology momentum may make Daiichi Sankyo worth a closer look.
Daiichi Sankyo’s oncology engine appears to be accelerating, while the dividend and fresh ¥200b loan keep the risk side of the story in focus. Get the full context in the analyst forecasts for Daiichi Sankyo Company
Seeking Alternatives Beyond Dividend Staples
Fresh ideas do not stay under the radar for long. Some stocks sit on the edge of a breakout while it still matters. If you want first-mover momentum, act now.
- Spot companies quietly building strength before the crowd notices by checking the curated 59 resilient stocks with low risk scores that still keep risk scores on a tight leash.
- Target growth stories already turning profits, not just burning cash, by scanning the hand picked 75 profitable AI stocks that aren't just burning cash that are riding real AI momentum.
- Position ahead of potential infrastructure shifts by reviewing the focused 40 power grid technology and infrastructure stocks that are tied to long term grid and electrification upgrades.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com